Skip to main content
. 2017 Nov;9(Suppl 15):S1511–S1523. doi: 10.21037/jtd.2017.09.82

Figure 4.

Figure 4

Patient affected by liver metastases from an atypical carcinoid, previously treated with surgery and SSA. The 68Ga-DOTATOC PET/CT (A, maximum intensity projection image) shows elevated SSR expression in the tumor lesions (B, baseline CT). The patient is treated with 177Lu-DOTATATE (cumulative activity 27.8 GBq), obtaining objective response (C, follow-up CT scan). PRRT, peptide receptor radionuclide therapy; SSA, somatostatin analog; SSR, somatostatin receptor.